Evidence map›Paper›PMID 40046154›Full record

SynthesisThe Brown journal of hospital medicine2023

Botulism in the 21st Century: A Scoping Review.

Ketino Kobaidze, Zanthia Wiley

Abstract readSystematic Review
In one paragraph

Synthesis in The Brown journal of hospital medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Botulinum neurotoxin: from molecular pathogenesis to emerging countermeasures.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ketino KobaidzeDepartment of Medicine, Division of Hospital Medicine Emory University School of Medicine, Atlanta, GA, USA.ORCID https://orcid.org/0000-0001-6249-8746
Zanthia WileyDepartment of Medicine, Division of Infectious Diseases Emory University School of Medicine, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Botulism is a potentially deadly neuroparalytic disease that affects all age groups; it is highly challenging to diagnose due to its nonspecific symptoms. Infant botulism is the most common form of botulism in the United States, followed by foodborne and wound botulism. Since most patients require hospitalization, it is imperative that both adult and pediatric physicians recognize its symptoms. Patients with severe forms of botulism typically present early after toxin ingestion and progress rapidly. Although rare in the United States, botulism remains a public health concern since even one case may predict an outbreak. This review summarizes the typical clinical course of botulism and recommendations for diagnosis and management.

Indexed as

botulinum antitoxinbotulinum toxinbotulismClostridium botulinumFoodborne botulism

Identifiers

PMID40046154
PMCPMC11878804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.